BackAlterity Therapeutics Overview

Alterity Therapeutics Cost of Revenue

Cost of Revenue analysis for ATHE.

Quarterly Cost of Revenue

$56828.00
78.71% YoY

As of Dec 31, 2025

Annual Cost of Revenue (TTM)

$184350.00
10.99% YoY

Trailing 12 months ending Dec 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)